407 completed, 73 unknown, 51 terminated, 28 recruiting. 605 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 605 | Completed 407, Unknown 73, Terminated 51, Recruiting 28, Withdrawn 21, Active not recruiting 12, Not yet recruiting 10, Enrolling by invitation 3 |
Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevent Wheeze Trial Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing | Phase 4 | Not yet recruiting | Norwegian University of Science and Technology | 486 | 2027-02-01 | 2026-10-05 |
| The LalelaLung Study: Digital Stethoscope Clinical Evaluation StethoMe AI-enabled digital stethoscope system, Standard IMCI assessment - Pneumonia, Tuberculosis, Pulmonary | Phase 4 | Not yet recruiting | Johns Hopkins University | 350 | 2026-11-02 | 2026-09-23 |
| Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate Fluticasone Propionate, Water Mouthwash, EVOOW Mouthwash - Asthma | Phase 4 | Not yet recruiting | University of Wisconsin, Madison | 20 | 2026-11-01 | 2026-09-24 |
| A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD) Belumosudil - Chronic Graft Versus Host Disease | Phase 4 | Not yet recruiting | Sanofi | 26 | 2026-10-30 | 2026-10-23 |
| Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum Rheology in Subjects With Mucus Hypersecretion Glycerol Guiacolate, SOC (Standard of care) - Bronchitis, Bronchitis, Chronic | Phase 4 | Not yet recruiting | University of North Carolina, Chapel Hill | 40 | 2026-10-01 | 2026-10-14 |
| Itraconazole Therapy In Bronchiectasis With Airway Mold Itraconazole 200 mg - Bronchiectasis, Fungal Infection of Upper Respiratory Tract | Phase 4 | Recruiting | Mayo Clinic | 30 | 2026-08-17 | 2026-08-21 |
| Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice ALK Alutard SQ Dog - Allergic Rhinitis, Asthma (Diagnosis) | Phase 4 | Recruiting | Karolinska Institutet | 40 | 2026-08-01 | 2026-06-29 |
| Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department Dexamethasone 16mg IM, Prednisone 60mg PO - Asthma | Phase 4 | Recruiting | Montefiore Medical Center | 182 | 2026-07-23 | 2026-07-24 |
| Fasenra: An Asthma Study Budesonide-albuterol, Benralizumab - Eosinophilic Asthma, Severe Asthma | Phase 4 | Enrolling by invitation | Endeavor Health | 40 | 2026-07-01 | 2026-09-15 |
| Azithromycin to Modify Bronchiectasis Exacerbation Risk Standard Bronchiectasis Care, Azithromycin, Matching Placebo - Non-cystic Fibrosis Bronchiectasis, Bronchiectasis Adult | Phase 4 | Recruiting | Assiut University | 500 | 2026-06-29 | 2026-09-24 |
| BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg]) Beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide (100/6/12.5 µg per actuation), Foster® 200/6 pMDI (BDP/FF-200/6 µg) - Asthma | Phase 4 | Recruiting | Chiesi Farmaceutici S.p.A. | 644 | 2026-06-28 | 2026-07-31 |
| Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP Anrikefon, Nalfurafine - Pruritus Chronic, Kidney Diseases, Chronic | Phase 4 | Recruiting | Zhujiang Hospital | 50 | 2026-06-22 | 2026-08-25 |
| Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC. Osimertinib+cisplatin or carboplatin + pemetrexed Edit - Non-small Cell Lung Cancer | Phase 4 | Recruiting | AstraZeneca | 100 | 2026-05-26 | 2026-10-16 |
| Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA) Tezepelumab, Placebo - Severe Asthma | Phase 4 | Recruiting | University of Alberta | 100 | 2026-05-11 | 2026-07-17 |
| Ventilation and Perfusion in Asthmatics Albuterol Sulfate, Albuterol-Budesonide - Asthma | Phase 4 | Recruiting | University of Miami | 40 | 2026-04-27 | 2026-10-23 |
| A Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients. DSP2505(Canium), Umckamin, Placebo Matching Umckamin - Acute Bronchitis | Phase 4 | Completed | Dasan Pharmaceutical Co., Ltd. | 223 | 2026-01-26 | 2026-09-23 |
| Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B Entecavir, Entecavir + Pegylated interferon α-2b - Hepatitis B Virus Infection, Children | Phase 4 | Not yet recruiting | Qing-Lei Zeng | 80 | 2026-01-11 | 2026-01-16 |
| Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B Entecavir, Entecavir + Pegylated interferon α-2b - Hepatitis B Virus Infection, Children | Phase 4 | Not yet recruiting | Qing-Lei Zeng | 60 | 2026-01-11 | 2026-01-16 |
| CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma Implementation bundle - Moderate to Severe Asthma | Phase 4 | Recruiting | Washington University School of Medicine | 2000 | 2026-01-06 | 2026-09-10 |
| Withdrawal of Dupilumab in Severe Asthma Stopping dupilumab - Severe Asthma | Phase 4 | Recruiting | University Hospital, Toulouse | 205 | 2025-12-15 | 2026-10-08 |
Showing 20 of 605. Sign in to see all of them.
Asthma (430) · Pulmonary Disease, Chronic Obstructive (62) · Bronchiolitis Obliterans Syndrome (53) · Bronchitis, Chronic (33) · Bronchiectasis (31) · Bronchitis (23) · Emphysema (18) · Bronchiolitis (17) · Rhinitis, Allergic (17) · Pulmonary Eosinophilia (15) · Respiratory Sounds (15) · Inflammation (10) · Emergencies (9) · Lung Diseases (9) · Pneumonia (9)
Respiratory Tract Diseases (601) · Lung Diseases, Obstructive (561) · Lung Diseases (560) · Immune System Diseases (492) · Hypersensitivity, Immediate (442) · Hypersensitivity (439) · Respiratory Hypersensitivity (434) · Pathological Conditions, Signs and Symptoms (151) · Pathologic Processes (109) · Bronchitis (106) · Infections (104) · Disease Attributes (94) · Respiratory Tract Infections (83) · Chronic Disease (82)
Albuterol (50) · Fluticasone (49) · montelukast (49) · Budesonide (41) · Fluticasone-Salmeterol Drug Combination (35) · Omalizumab (24) · Formoterol Fumarate (23) · Salmeterol Xinafoate (22) · Beclomethasone (18) · Azithromycin (17) · Budesonide, Formoterol Fumarate Drug Combination (14) · Sodium Chloride (13) · Mometasone Furoate (12) · Tiotropium Bromide (12) · dupilumab (12)
GlaxoSmithKline (53) · AstraZeneca (24) · Organon and Co (19) · University of Dundee (13) · University of Saskatchewan (12) · Novartis Pharmaceuticals (10) · Sanofi (10) · Medical University of Lodz (9) · Centre of Chinese Medicine, Georgia (8) · Imperial College London (8) · Johns Hopkins University (7) · Bispebjerg Hospital (6) · Boehringer Ingelheim (6) · Novartis (6) · Teva Branded Pharmaceutical Products R&D, Inc. (6)
United States (196) · Canada (64) · United Kingdom (61) · China (45) · Germany (36) · Italy (33) · Spain (33) · Belgium (27) · France (25) · Netherlands (25) · Denmark (24) · Poland (22) · Sweden (18) · South Korea (14) · Brazil (13)
Don Cockcroft, MD (6) · Iwona Stelmach, MD, PhD, Prof (6) · Manana Tchaia, MD (6) · Merab Lomia, MD, PhD (6) · Adam T Hill, MBChB MD (5) · Brian Lipworth, MD (5) · Konrad E Bloch, MD (5) · Leslie Hendeles, PharmD (4) · Tamara Tchelidze, MD (4) · Brian J Lipworth, MBchB (3)
PMID 20167147, PMID 20870753, PMID 32298853, PMID 33369570, PMID 34433773, PMID 36472162, PMID 37347518, PMID 37536444, PMID 37952772, PMID 10109801, PMID 11113831, PMID 11511368, PMID 11825832, PMID 12045120, PMID 12095178, PMID 12403874, PMID 12612294, PMID 1285737, PMID 12927665, PMID 15229100, PMID 15672845, PMID 15741443, PMID 15823451, PMID 15922813, PMID 16113473, PMID 16226443, PMID 16478839, PMID 16597501, PMID 16650970, PMID 16687712, PMID 17035697, PMID 17046300, PMID 17053496, PMID 17075269, PMID 17507702, PMID 17610727, PMID 17629923, PMID 17652648, PMID 17766511, PMID 17931847, PMID 18006882, PMID 18025315, PMID 18331513, PMID 18583517, PMID 18828160, PMID 18951618, PMID 18990678, PMID 19127072, PMID 19134016, PMID 19164187
2019 (6), 2015 (5), 2014 (4), 2017 (4), 2018 (3), 2025 (3), 2005 (2), 2016 (2), R01AT007987 (2), 2009 (1), 2023 (1), K23HL171940 (1), N01MH090003 (1), P01HL128191 (1), P50HL056385 (1)